# A Study Designed to Determine if the Pharmacokinetic Disposition of Inhaled Insulin Exposure is the Same for Asthmatics and Non-asthmatics

> **NCT00673621** · PHASE1 · COMPLETED · sponsor: **Mannkind Corporation** · enrollment: 30 (actual)

## Conditions studied

- Asthma
- Diabetes Mellitus

## Interventions

- **DRUG:** Technosphere Insulin Inhalation Powder
- **DRUG:** Salbutamol (Albuterol)
- **DRUG:** Methacholine chloride

## Key facts

- **NCT ID:** NCT00673621
- **Lead sponsor:** Mannkind Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2008-11
- **Final completion:** 2008-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2012-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00673621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00673621, "A Study Designed to Determine if the Pharmacokinetic Disposition of Inhaled Insulin Exposure is the Same for Asthmatics and Non-asthmatics". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00673621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*